| Title |
Fluphenazine decanoate (depot) and enanthate for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2015
|
| DOI | 10.1002/14651858.cd000307.pub2 |
| Pubmed ID | |
| Authors |
Nicola Maayan, Seema N Quraishi, Anthony David, Aprajita Jayaswal, Maurice Eisenbruch, John Rathbone, Rosie Asher, Clive E Adams |
| Abstract |
Intramuscular injections (depot preparations) offer an advantage over oral medication for treating schizophrenia by reducing poor compliance. The benefits gained by long-acting preparations, however, may be offset by a higher incidence of adverse effects. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 287 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | <1% |
| Unknown | 286 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 45 | 16% |
| Student > Bachelor | 38 | 13% |
| Student > Ph. D. Student | 28 | 10% |
| Researcher | 26 | 9% |
| Other | 17 | 6% |
| Other | 51 | 18% |
| Unknown | 82 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 75 | 26% |
| Nursing and Health Professions | 29 | 10% |
| Psychology | 27 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 6% |
| Social Sciences | 11 | 4% |
| Other | 38 | 13% |
| Unknown | 91 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2023.
All research outputs
#20,011,936
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#10,818
of 11,499 outputs
Outputs of similar age
#254,594
of 361,053 outputs
Outputs of similar age from Cochrane database of systematic reviews
#221
of 236 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,053 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.